Table 1

Genes downregulated by AI treatment

ID
Symbol
Description
Unigene
Fold
LFDR

HSI182A05
TFF1
Trefoil factor 1 (breast cancer, estrogen-inducible)
Hs.162807
0.26
0.09
HSI054D07
HBB
Haemoglobin, beta
Hs.523443
0.31
0.00
HSI047B01
PDZK1
PDZ domain containing 1
Hs.444751
0.35
0.00
HSI035H02
CYP2B6
Cytochrome P450, family 2B6
Hs.1360
0.41
0.04
HSI075H09
AGR2
Anterior gradient 2 homolog (Xenopus laevis)
Hs.530009
0.41
0.08
HSI031E07
STARD10
START domain containing 10
Hs.188606
0.42
0.00
HSI183G10
TFF3
Trefoil factor 3 (intestinal)
Hs.82961
0.43
0.00
HSI147F09
ZBTB20
Zinc finger and BTB domain containing 20
Hs.570657
0.45
0.00
HSI182A08
STC2
Stanniocalcin 2
Hs.233160
0.47
0.00
HSI147F08
KTN1
Kinectin 1 (kinesin receptor)
Hs.509414
0.47
0.00
HSI059H10
LOC143381
Hypothetical protein LOC143381
Hs.388347
0.47
0.00
HSI147F10
MSI2
Musashi homolog 2 (Drosophila)
Hs.134470
0.49
0.00
HSI177G07
EST
Transcribed locus
Hs.443277
0.50
0.10
HSI053H02
UBE2C
Ubiquitin-conjugating enzyme E2C
Hs.93002
0.52
0.10
HSI096C06
MAPT
Microtubule-associated protein tau
Hs.101174
0.52
0.00
HSI049A02
ERGIC1
ER-golgi intermediate compartment 1
Hs.509163
0.53
0.09
HSI040C08
AZGP1
Alpha-2-glycoprotein 1, zinc
Hs.546239
0.55
0.00
HSI133F06
EST
Transcribed locus
Hs.159264
0.55
0.00
HSI182E08
PLAT
Plasminogen activator, tissue
Hs.491582
0.55
0.00
HSI033B05
LY6E
Lymphocyte antigen 6 complex, locus E
Hs.521903
0.56
0.00
HSI048F12
CCND1
Cyclin D1
Hs.523852
0.56
0.10
HSI085G12
KCNK15
Potassium channel, subfamily K, member 15
Hs.528664
0.57
0.00
HSI177H07
PCBP3
Poly(rC) binding protein 3
Hs.474049
0.57
0.10
HSI032D02
ABCA3
ATP-binding cassette, subfamily A3 (ABC1)
Hs.26630
0.57
0.00
HSI182A02
TFF3
Trefoil factor 3 (intestinal)
Hs.82961
0.58
0.04
HSI025A03
FGD3
FYVE, RhoGEF and PH domain containing 3
Hs.411081
0.58
0.00
HSI070B06
AP1S1
Adaptor-related protein complex 1, sigma 1 subunit
Hs.489365
0.58
0.08
HSI057H12
GNB2
Guanine nucleotide binding protein beta 2
Hs.185172
0.58
0.00
HSI080H11
SEMA3F
Semaphorin 3F
Hs.32981
0.59
0.00
HSI054G06
NUSAP1
Nucleolar and spindle associated protein 1
Hs.511093
0.59
0.00
HSI124D07
RIMS4
Regulating synaptic membrane exocytosis 4
Hs.517065
0.59
0.00
HSI065C09
CNNM2
Cyclin M2
Hs.500903
0.59
0.00
HSI080F02
PREX1
PIP3-dependent RAC exchanger 1
Hs.153310
0.59
0.00
HSI095H09
C6orf97
Chromosome 6 open reading frame 97
Hs.130239
0.59
0.00
HSI161G02
EST
Transcribed locus
Hs.570637
0.60
0.00
HSI045G02
UBE2T
Ubiquitin-conjugating enzyme E2T (putative)
Hs.5199
0.60
0.00
HSI046F10
TOP2A
Topoisomerase (DNA) II alpha 170 kDa
Hs.156346
0.60
0.00
HSI183D04
AR
Androgen receptor
Hs.496240
0.61
0.01
HSI183A08
SLC9A3R1
Solute carrier family 9, member 3 regulator 1
Hs.396783
0.61
0.00
HSI025G02
SHARPIN
SHANK-associated RH domain interactor
Hs.529755
0.61
0.08

Shown are the first 40 downregulated genes from a paired SAM analysis, which identified 1,264 genes to be downregulated by aromatase inhibitor (AI) treatment below a local false discovery rate of 1% (LFDR). The genes are ranked according to their fold change.

Mackay et al. Breast Cancer Research 2007 9:R37   doi:10.1186/bcr1732